(NP (NP (NP Comparison/NN) (PP of/IN (NP (NP (ADJP-COOD (ADJP constitutive/JJ) and/CC (ADJP inducible/JJ)) transcriptional/JJ enhancement/NN) (VP mediated/VBN (NP */-NONE-) (PP by/IN (NP-LGS (ADJP kappa/NN B-related/JJ) sequences/NNS))))) :/:) (NP (NP modulation/NN) (PP of/IN (NP (NP activity/NN) (PP in/IN (NP B/NN cells/NNS)))) (PP by/IN (NP human/JJ T-cell/NN leukemia/NN virus/NN type/NN I/CD tax/NN gene/NN)) ./.))
(S (NP-SBJ (NP The/DT kappa/NN B/NN sequence/NN) (PRN -LRB-/-LRB- (NP GGGACTTTCC/NN) -RRB-/-RRB-)) (VP binds/VBZ (NP (NP (NP a/DT factor/NN) ,/, (NP NF-kappa/NN B/NN) ,/,) (SBAR (WHNP-75 that/WDT) (S (NP-SBJ-76 *T*-75/-NONE-) (VP is/VBZ (ADVP constitutively/RB) (VP found/VBN (NP *-76/-NONE-) (PP in/IN (NP its/PRP$ (ADJP-COOD (ADJP functional/JJ) ,/, (ADJP DNA/NN binding/NN)) form/NN)) (PP only/RB in/IN (NP B/NN lymphocytes/NNS)))))))) ./.)
(S (NP-SBJ-77 (NP A/DT factor/NN) (PP with/IN (NP (ADJP apparently/RB indistinguishable/JJ) sequence/NN specificity/NN))) (VP can/MD (VP be/VB (VP induced/VBN (NP *-77/-NONE-) (PP in/IN (NP (NP many/JJ other/JJ cell/NN types/NNS) ,/, (SBAR (WHADVP-78 where/WRB) (S (NP-SBJ-79 it/PRP) (VP is/VBZ (VP used/VBN (NP-80 *-79/-NONE-) (S (NP-SBJ *-80/-NONE-) (VP to/TO (VP regulate/VB (NP inducible/JJ gene/NN expression/NN))))))))))))) ./.)
(S (PP For/IN (NP example/NN)) ,/, (NP-SBJ-81 (ADJP kappa/NN B-related/JJ) sequences/NNS) (VP have/VBP (VP been/VBN (VP shown/VBN (S (NP-SBJ *-81/-NONE-) (VP to/TO (VP be/VB (ADJP-PRD important/JJ (PP for/IN (NP (NP the/DT transcription/NN) (PP of/IN (NP (NP (QP a/DT few/JJ) inducible/JJ genes/NNS) ,/, (PP such/JJ as/IN (NP-COOD (NP the/DT interleukin/NN 2/CD receptor/NN alpha-chain/NN gene/NN) and/CC (NP the/DT beta-interferon/NN gene/NN)))))))))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ these/DT genes/NNS) (VP are/VBP not/RB (ADJP-PRD constitutively/RB active/JJ (PP in/IN (NP B/NN lymphocytes/NNS))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ other/JJ regulatory/JJ mechanisms/NNS) (VP must/MD (VP play/VB (NP a/DT role/NN) (PP in/IN (S (NP-SBJ */-NONE-) (VP determining/VBG (NP (NP the/DT patterns/NNS) (PP of/IN (NP expression/NN))))))))))))) ./.)
(S (NP-SBJ We/PRP) (VP have/VBP (VP investigated/VBN (NP (NP the/DT (ADJP-COOD (ADJP constitutive/JJ) and/CC (ADJP inducible/JJ)) transcriptional/JJ activity/NN) (VP mediated/VBN (PP by/IN (NP (NP five/CD (ADJP kappa/NN B-related/JJ) sequence/NN elements/NNS) (PP in/IN (NP two/CD different/JJ cell/NN types/NNS)))))))) ./.)
(S (NP-SBJ We/PRP) (VP show/VBP (SBAR that/IN (S (PP in/IN (NP S194/NN plasma/NN cells/NNS)) (NP-SBJ (NP the/DT activity/NN) (PP of/IN (NP each/DT element/NN))) (VP correlates/VBZ (ADVP well/RB) (PP with/IN (NP (NP the/DT relative/JJ affinity/NN) (PP of/IN (NP B-cell-derived/JJ NF-kappa/NN B/NN)) (PP for/IN (NP that/DT element/NN)))))))) ./.)
(S (NP-SBJ This/DT) (VP leads/VBZ (PP to/TO (NP (NP (ADJP significantly/RB lower/RBR) transcription/NN enhancement/NN) (PP by/IN (NP (NP sites/NNS) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP (NP the/DT (NP-COOD (NP interleukin/NN 2/CD receptor/NN) or/CC (NP T-cell/NN receptor/NN)) genes/NNS) (PP in/IN (NP (NP S194/NN) cells/NNS)))))))))) ./.)
(S (ADVP However/RB) ,/, (PP in/IN (NP-COOD either/CC (NP EL-4/NN -LRB-/-LRB- T/NN -RRB-/-RRB- cells/NNS) or/CC (NP S194/NN cells/NNS))) ,/, (NP-SBJ-83 both/DT lower-affinity/JJ sites/NNS) (VP can/MD (VP be/VB (ADVP significantly/RB) (VP induced/VBN (NP *-83/-NONE-) (PP by/IN (NP-LGS (NP the/DT tax/NN gene/NN product/NN) (PP of/IN (NP human/JJ T-cell/NN leukemia/NN virus/NN type/NN I/CD)))) ,/, (S-ADV (NP-SBJ */-NONE-) (VP showing/VBG (SBAR that/IN (S (NP-SBJ-84 NF-kappa/NN B/NN activity/NN) (VP can/MD (VP be/VB (VP modulated/VBN (NP *-84/-NONE-) (PP even/RB in/IN (NP (NP a/DT B-cell/NN line/NN) (SBAR (WHNP-85 that/WDT) (S (NP-SBJ *T*-85/-NONE-) (ADVP constitutively/RB) (VP expresses/VBZ (NP this/DT factor/NN)))))))))))))))) ./.)
